The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China
Objectives: The present study aimed to compare the clinicopathological features of patients with seronegative immune-mediated necrotizing myopathy (IMNM) and those positive for anti-signal recognition particle (SRP) or anti-3-hydroxy-3-methylglutarylcoenzyme-a reductase (HMGCR) antibodies.Methods: W...
Main Authors: | Xue Ma, Li Xu, Suqiong Ji, Yue Li, Bitao Bu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.670784/full |
Similar Items
-
Necrotizing autoimmune myopathy: Clinicopathologic study from a single tertiary care centre
by: Sobiya Mahnaz Ayesha, et al.
Published: (2018-01-01) -
Autoimmune statin-induced myopathy: a case report
by: Jonathan B. Young, et al.
Published: (2015-09-01) -
Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report
by: Rhys Thomas, et al.
Published: (2020-06-01) -
Statins and Immune-Mediated Necrotizing Myopathy
by: Mauro Turrin
Published: (2018-10-01) -
Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report
by: Sunita Upreti, et al.
Published: (2019-01-01)